A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Tolerability of Molecular Hydrogen in Patients with Parkinson’s Disease

This study investigated the safety and tolerability of molecular hydrogen, a promising antioxidant agent, in patients with early-stage Parkinson’s disease.